Collectively, our results suggest upregulation of ASCL1 in SCLC cells transcriptionally activates the DARPP-32 promoter contributing to overexpression of DARPP-32 and t-DARPP proteins, which promote SCLC growth through anti-apoptotic and pro-survival signalling. This evidence concerns the gene ASCL1 and small cell lung carcinoma.